Intimidation of initiation of Trading Window Closure for the Quarter ended on 31st December, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Skybiotech Healthcare has informed the BSE that its trading window will be closed from 1 January 2026 until 48 hours after the declaration of its unaudited financial results for the quarter ended 31 December 2025. During this period, all Designated Persons and their immediate relatives are prohibited from buying or selling shares of the company. The closure is as per SEBI's Insider Trading Regulations, 2015 and the company's internal Code of Conduct. The date of the Board Meeting to approve these quarterly results will be announced later.
This is a routine regulatory filing — no direct impact on shareholders. However, the upcoming results declaration (likely in early-to-mid January 2026) is the key event to watch. Notably, the company's quarterly results have historically been delayed, and its shares are illiquid, so the announcement timing deserves close attention.